Citigroup’s Adeptus Health Inc ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-32,816
Closed -$59K 7693
2017
Q1
$59K Buy
32,816
+19,237
+142% +$108K ﹤0.01% 5591
2016
Q4
$104K Buy
13,579
+6,128
+82% +$113K ﹤0.01% 5752
2016
Q3
$321K Buy
7,451
+7,293
+4,616% +$329K ﹤0.01% 4295
2016
Q2
$8K Sell
158
-4,127
-96% -$247K ﹤0.01% 6671
2016
Q1
$238K Buy
4,285
+4,261
+17,754% +$220K ﹤0.01% 4919
2015
Q4
$1K Sell
24
-3,105
-99% -$198K ﹤0.01% 7476
2015
Q3
$253K Buy
3,129
+2,323
+288% +$240K ﹤0.01% 4312
2015
Q2
$77K Buy
806
+494
+158% +$34K ﹤0.01% 5213
2015
Q1
$16K Sell
312
-651
-68% -$25.8K ﹤0.01% 6226
2014
Q4
$36K Buy
963
+766
+389% +$24.1K ﹤0.01% 5909
2014
Q3
$5K Buy
+197
New +$5.14K ﹤0.01% 6599

Other funds holding ADPT

Citigroup's ADPT Position: Q2 2017 in Review

Citigroup sold out of Adeptus Health Inc (ADPT) in Q2 2017, closing a stake of 32,816 shares — an estimated $59K sold.

Citigroup first reported a position in ADPT in Q3 2014 and held it in 11 quarters. The position peaked at $321K in Q3 2016. 9 funds tracked by Wall St. Rank hold ADPT as of Q2 2017.

  • Citigroup reported no remaining Adeptus Health Inc position as of Q2 2017 after selling out during the quarter.
  • Citigroup sold 32,816 Adeptus Health Inc shares in Q2 2017, an estimated $59K.
  • Citigroup first reported a position in Adeptus Health Inc in Q3 2014 and held it in 11 quarters.
  • Citigroup's Adeptus Health Inc position peaked at $321K in Q3 2016.
  • 9 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q2 2017.

Based on Citigroup's 13F filing for Q2 2017, filed 11 Aug 2017.